Immunohistochemical expression of cAMP in fluoroedenite‑induced malignant pleural mesothelioma: <br />Preliminary results

Broggi,Giuseppe; Filetti,Veronica; Magro,Gaetano; Morante,Brunella; Garro,Rossella; Ledda,Caterina; Rapisarda,Venerando; Lombardo,Claudia; Loreto,Carla; Caltabiano,Rosario

doi:10.3892/mmr.2023.13019

Immunohistochemical expression of cAMP in fluoroedenite‑induced malignant pleural mesothelioma:
Preliminary results

Authors:
- Giuseppe Broggi
- Veronica Filetti
- Gaetano Magro
- Brunella Morante
- Rossella Garro
- Caterina Ledda
- Venerando Rapisarda
- Claudia Lombardo
- Carla Loreto
- Rosario Caltabiano
View Affiliations

Affiliations: Department of Medical, Surgical Sciences and Advanced Technologies G.F. Ingrassia, Anatomic Pathology, University of Catania, I‑95123 Catania, Italy, Human Anatomy and Histology Division, Department of Biomedical and Biotechnology Sciences, University of Catania, I‑95123 Catania, Italy, Occupational Medicine Division, Department of Clinical and Experimental Medicine, University of Catania, I‑95123 Catania, Italy
Published online on: May 22, 2023 https://doi.org/10.3892/mmr.2023.13019
Article Number: 132

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Despite advances in understanding of the biology of malignant pleural mesothelioma (MPM), the prognosis of this malignancy remains poor. Although asbestos still remains the main pathogenic agent of MPM, other asbestos‑like fibers such as fluoro‑edenite (FE) fibers, induce MPM. Notable incidence and mortality rates of MPM have been found in Biancavilla, Italy, where FE fibers have been extracted from building materials for >50 years. Cyclic adenosine monophosphate (cAMP) is a secondary messenger that plays a key role in several physiological and pathological mechanisms regulating protein kinase A (PKA) and the CREB pathway. Hyperactivation of the cAMP/PKA/CREB pathway is involved in many neoplastic processes, including tumor cell proliferation, invasion and metastatic spread. The present study investigated immunohistochemical expression of cAMP in patients with FE‑induced MPM, which included six males and four females with an age range of 50‑93 years. There was high immunoexpression of cAMP in 5 out of 10 tumors while the remaining 5 cases showed low immunoexpression. In addition, there was a correlation between cAMP overexpression and decreased survival times (mean overall survival times, 7.5 months in high expression group vs. 18 months in low expression group).

View References

1	Perera ND and Mansfield AS: The evolving therapeutic landscape for malignant pleural mesothelioma. Curr Oncol Rep. 24:1413–1423. 2022. View Article : Google Scholar : PubMed/NCBI
2	Sinn K, Mosleh B and Hoda MA: Malignant pleural mesothelioma: Recent developments. Curr Opin Oncol. 33:80–86. 2021. View Article : Google Scholar : PubMed/NCBI
3	Delgermaa V, Takahashi K, Park EK, Le GV, Hara T and Sorahan T: Global mesothelioma deaths reported to the world health organization between 1994 and 2008. Bull World Health Organ. 89:716–724. 2011. View Article : Google Scholar : PubMed/NCBI
4	Rapisarda V, Ledda C, Migliore M, Salemi R, Musumeci A, Bracci M, Marconi A, Loreto C and Libra M: FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: A pilot study. Future Oncol. 11:35–37. 2015. View Article : Google Scholar : PubMed/NCBI
5	Rapisarda V, Broggi G, Caltabiano R, Lombardo C, Castorina S, Trovato A, Ledda C, Filetti V and Loreto C: ATG7 immunohistochemical expression in malignant pleural mesothelioma. A preliminary report. Histol Histopathol. 36:1301–1308. 2021.PubMed/NCBI
6	Broggi G, Angelico G, Filetti V, Ledda C, Lombardo C, Vitale E, Rapisarda V, Loreto C and Caltabiano R: Immunohistochemical expression of serine and arginine-rich splicing factor 1 (SRSF1) in fluoro-edenite-induced malignant mesothelioma: A preliminary study. Int J Environ Res Public Health. 18:62492021. View Article : Google Scholar : PubMed/NCBI
7	Filetti V, Vitale E, Broggi G, Hagnäs MP, Candido S, Spina A and Lombardo C: Update of in vitro, in vivo and ex vivo fluoro-edenite effects on malignant mesothelioma: A systematic review (Review). Biomed Rep. 13:602020. View Article : Google Scholar : PubMed/NCBI
8	Ledda C, Loreto C, Pomara C, Rapisarda G, Fiore M, Ferrante M, Bracci M, Santarelli L, Fenga C and Rapisarda V: Sheep lymph-nodes as a biological indicator of environmental exposure to fluoro-edenite. Environ Res. 147:97–101. 2016. View Article : Google Scholar : PubMed/NCBI
9	Filetti V, Loreto C, Falzone L, Lombardo C, Cannizzaro E, Castorina S, Ledda C and Rapisarda V: Diagnostic and prognostic value of three microRNAs in environmental asbestiform fibers-associated malignant mesothelioma. J Pers Med. 11:12052021. View Article : Google Scholar : PubMed/NCBI
10	Paoletti L, Batisti D, Bruno C, Di Paola M, Gianfagna A, Mastrantonio M, Nesti M and Comba P: Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: An epidemiological and environmental study. Arch Environ Health. 55:392–398. 2000. View Article : Google Scholar : PubMed/NCBI
11	Comba P, Gianfagna A and Paoletti L: Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole. Arch Environ Health. 58:229–232. 2003. View Article : Google Scholar : PubMed/NCBI
12	Grosse Y, Loomis D, Guyton KZ, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H, et al: Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. Lancet Oncol. 15:1427–1428. 2014. View Article : Google Scholar : PubMed/NCBI
13	Zhang H, Kong Q, Wang J, Jiang Y and Hua H: Complex roles of cAMP-PKA-CREB signaling in cancer. Exp Hematol Oncol. 9:322020. View Article : Google Scholar : PubMed/NCBI
14	Jackson EK: The 2′,3′-cAMP-adenosine pathway. Am J Physiol Renal Physiol. 301:F1160–F1167. 2011. View Article : Google Scholar : PubMed/NCBI
15	Broggi G, Lo Giudice A, Di Mauro M, Pricoco E, Piombino E, Ferro M, Caltabiano R, Morgia G and Russo GI: Insulin signaling, androgen receptor and PSMA immunohistochemical analysis by semi-automated tissue microarray in prostate cancer with diabetes (DIAMOND study). Transl Res. 238:25–35. 2021. View Article : Google Scholar : PubMed/NCBI
16	Broggi G, Lo Giudice A, Di Mauro M, Asmundo MG, Pricoco E, Piombino E, Caltabiano R, Morgia G and Russo GI: SRSF-1 and microvessel density immunohistochemical analysis by semi-automated tissue microarray in prostate cancer patients with diabetes (DIAMOND study). Prostate. 81:882–892. 2021. View Article : Google Scholar : PubMed/NCBI
17	Galateau-Salle F, Churg A, Roggli V and Travis WD; World Health Organization Committee For Tumors Of The Pleura, : The 2015 world health organization classification of tumors of the pleura: Advances since the 2004 classification. J Thorac Oncol. 11:142–154. 2016. View Article : Google Scholar : PubMed/NCBI
18	Massimi M, Ragusa F, Cardarelli S and Giorgi M: Targeting cyclic AMP signalling in hepatocellular carcinoma. Cells. 8:15112019. View Article : Google Scholar : PubMed/NCBI
19	Massimi M, Cardarelli S, Galli F, Giardi MF, Ragusa F, Panera N, Cinque B, Cifone MG, Biagioni S and Giorgi M: Increase of intracellular cyclic AMP by PDE4 inhibitors affects HepG2 cell cycle progression and survival. J Cell Biochem. 118:1401–1411. 2017. View Article : Google Scholar : PubMed/NCBI
20	Tonucci FM, Almada E, Borini-Etichetti C, Pariani A, Hidalgo F, Rico MJ, Girardini J, Favre C, Goldenring JR, Menacho-Marquez M and Larocca MC: Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis. Cancer Lett. 461:65–77. 2019. View Article : Google Scholar : PubMed/NCBI
21	Chen TC, Hinton DR, Zidovetzki R and Hofman FM: Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab Invest. 78:165–174. 1998.PubMed/NCBI
22	Moon EY, Lee GH, Lee MS, Kim HM and Lee JW: Phosphodiesterase inhibitors control A172 human glioblastoma cell death through cAMP-mediated activation of protein kinase A and Epac1/Rap1 pathways. Life Sci. 90:373–380. 2012. View Article : Google Scholar : PubMed/NCBI
23	Cohen JR, Resnick DZ, Niewiadomski P, Dong H, Liau LM and Waschek JA: Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumor sphere cultures. BMC Cancer. 10:6762010. View Article : Google Scholar : PubMed/NCBI
24	Ge X, Milenkovic L, Suyama K, Hartl T, Purzner T, Winans A, Meyer T and Scott MP: Phosphodiesterase 4D acts downstream of Neuropilin to control Hedgehog signal transduction and the growth of medulloblastoma. Elife. 4:e070682015. View Article : Google Scholar : PubMed/NCBI
25	Neary CL, Nesterova M, Cho YS, Cheadle C, Becker KG and Cho-Chung YS: Protein kinase A isozyme switching: Eliciting differential cAMP signaling and tumor reversion. Oncogene. 23:8847–8856. 2004. View Article : Google Scholar : PubMed/NCBI
26	Pollack A, Bae K, Khor LY, Al-Saleem T, Hammond ME, Venkatesan V, Byhardt RW, Asbell SO, Shipley WU and Sandler HM: The importance of protein kinase A in prostate cancer: Relationship to patient outcome in radiation therapy oncology group trial 92-02. Clin Cancer Res. 15:5478–5484. 2009. View Article : Google Scholar : PubMed/NCBI
27	Kok M, Zwart W, Holm C, Fles R, Hauptmann M, Veer LJ, Wessels LF, Neefjes J, Stål O, Linn SC, et al: PKA-induced phosphorylation of ERα at serine 305 and high PAK1 levels is associated with sensitivity to tamoxifen in ER-positive breast cancer. Breast Cancer Res Treat. 125:1–12. 2011. View Article : Google Scholar : PubMed/NCBI
28	Moody SE, Schinzel AC, Singh S, Izzo F, Strickland MR, Luo L, Thomas SR, Boehm JS, Kim SY, Wang ZC and Hahn WC: PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling. Oncogene. 34:2061–2071. 2015. View Article : Google Scholar : PubMed/NCBI
29	Shukla A, Bosenberg MW, MacPherson MB, Butnor KJ, Heintz NH, Pass HI, Carbone M, Testa JR and Mossman BT: Activated cAMP response element binding protein is overexpressed in human mesotheliomas and inhibits apoptosis. Am J Pathol. 175:2197–2206. 2009. View Article : Google Scholar : PubMed/NCBI
30	Stoppoloni D, Salvatori L, Biroccio A, D'Angelo C, Muti P, Verdina A, Sacchi A, Vincenzi B, Baldi A and Galati R: Aromatase inhibitor exemestane has antiproliferative effects on human mesothelioma cells. J Thorac Oncol. 6:583–591. 2011. View Article : Google Scholar : PubMed/NCBI
31	Nuvoli B and Galati R: Cyclooxygenase-2, epidermal growth factor receptor, and aromatase signaling in inflammation and mesothelioma. Mol Cancer Ther. 12:844–852. 2013. View Article : Google Scholar : PubMed/NCBI
32	Nuvoli B, Germoni S, Morosetti C, Santoro R, Cortese G, Masi S, Cordone I and Galati R: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease. Mol Cancer. 13:692014. View Article : Google Scholar : PubMed/NCBI
33	Li Q, Wang W, Yamada T, Matsumoto K, Sakai K, Bando Y, Uehara H, Nishioka Y, Sone S, Iwakiri S, et al: Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network. Am J Pathol. 179:1483–1493. 2011. View Article : Google Scholar : PubMed/NCBI
34	Marino FZ, Corte CM, Ciaramella V, Erra S, Ronchi A, Fiorelli A, Vicidomini G, Santini M, Scognamiglio G, Morgillo F, et al: AXL and MET tyrosine kinase receptors co-expression as a potential therapeutic target in malignant pleural mesothelioma. J Pers Med. 12:19932022. View Article : Google Scholar